In vitro phosphate binding capacity of a dietary supplement for dogs and cats
N Bruni, E Martello, R Adami, G Meineri… - … and Nutrition …, 2022 - set-publisher.com
… mainly based on reducing phosphorus in the diet and with phosphate (P) binders. In this in
… The aim of our in vitro study is the comparison of phosphate binding activity at pH 3 and 7 …
… The aim of our in vitro study is the comparison of phosphate binding activity at pH 3 and 7 …
[HTML][HTML] Small intestinal phosphate absorption: novel therapeutic implications
J Yee, D Rosenbaum, JW Jacobs… - American Journal of …, 2021 - karger.com
… In animal and in vitro models of human small intestinal enteroids, NHE3 inhibition increases
… reduced phosphate absorption and facilitated a 50% reduction in phosphate binder dose […
… reduced phosphate absorption and facilitated a 50% reduction in phosphate binder dose […
Focusing on phosphorus loads: from healthy people to chronic kidney disease
M Wang, J Zhang, K Kalantar-Zadeh, J Chen - Nutrients, 2023 - mdpi.com
… outcomes involved in in vivo phosphorus regulation. Six healthy … Additionally, this theory still
cannot explain the persistent … , which induces reduction in phosphorus load into the bones of …
cannot explain the persistent … , which induces reduction in phosphorus load into the bones of …
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
U Thiem, TD Hewitson, ND Toussaint… - Nephrology Dialysis …, 2023 - academic.oup.com
… Since the mineral load associated with CPP-II should theoretically be a product of both … in
vitro, we hypothesised that lowering serum CPPs with high-dose SO should decrease the pro-…
vitro, we hypothesised that lowering serum CPPs with high-dose SO should decrease the pro-…
Phosphate, microbiota and CKD
… While both maneuvers may theoretically modulate the gut … -dialysis CKD patients and in
vitro binding to microbiota-derived … reducing dietary phosphate absorption, phosphate binders …
vitro binding to microbiota-derived … reducing dietary phosphate absorption, phosphate binders …
Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats
AJ King, J Kohler, C Fung, Z Jiang… - American Journal …, 2021 - journals.physiology.org
… hyperphosphatemia aims to reduce intestinal phosphate absorption by combining dietary …
calculated using the complete additivity of probability theory based on the observed effect of …
calculated using the complete additivity of probability theory based on the observed effect of …
In search of an efficient complexing agent for oxalates and phosphates: a quantum chemical study
… They might therefore be used to reduce intestinal oxalate absorption in patients … theoretical
predictions will suggest new complexes for further investigation in silico, in vitro and/or in vivo …
predictions will suggest new complexes for further investigation in silico, in vitro and/or in vivo …
Phosphorus metabolism and fibroblast growth factor 23 in chronic kidney disease
A Bansal, M Chonchol - Nutritional management of renal disease, 2022 - Elsevier
… phosphate concentrations induced calcification in vitro, … , interventions to reduce intestinal
phosphate absorption should lead … Another theoretical approach would be to use exogenous …
phosphate absorption should lead … Another theoretical approach would be to use exogenous …
Dietary phosphorus as a marker of mineral metabolism and progression of diabetic kidney disease
A Winiarska, I Filipska, M Knysak, T Stompór - Nutrients, 2021 - mdpi.com
… from reduced intake and use of phosphate binders into the use of … phosphate binders vs
placebo [95,96]. Clinically unproven and rather theoretical benefits of phosphate binder use are …
placebo [95,96]. Clinically unproven and rather theoretical benefits of phosphate binder use are …
[HTML][HTML] Phosphate balance and CKD–mineral bone disease
SM Sprague, KJ Martin, DW Coyne - Kidney International Reports, 2021 - Elsevier
… Phosphate binders reduce available phosphate for intestinal absorption but do not impair
the dominant phosphate … modifiable risk factor for theoretically lowering CV morbidity and …
the dominant phosphate … modifiable risk factor for theoretically lowering CV morbidity and …